Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
1.010
+0.010 (1.01%)
Nov 21, 2024, 1:49 PM EST - Market open
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 4.00, with a low estimate of 1.00 and a high estimate of 7.00. The average target predicts an increase of 296.04% from the current stock price of 1.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NKTR stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +593.07% | Nov 4, 2024 |
| BTIG | BTIG | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +296.04% | Sep 30, 2024 |
| Jefferies | Jefferies | Hold Maintains $0.5 → $1 | Hold | Maintains | $0.5 → $1 | -0.99% | Mar 6, 2024 |
| JP Morgan | JP Morgan | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Nov 20, 2023 |
| TD Cowen | TD Cowen | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 9, 2023 |
Financial Forecast
Revenue This Year
86.33M
from 90.12M
Decreased by -4.21%
Revenue Next Year
80.09M
from 86.33M
Decreased by -7.22%
EPS This Year
-0.84
from -1.45
EPS Next Year
-0.70
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 103.6M | 128.3M | 135.1M | ||
| Avg | 86.3M | 80.1M | 83.0M | ||
| Low | 53.4M | 22.4M | 23.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 14.9% | 48.6% | 68.7% | ||
| Avg | -4.2% | -7.2% | 3.7% | ||
| Low | -40.7% | -74.0% | -71.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.80 | -0.34 | -0.21 |
| Avg | -0.84 | -0.70 | -0.66 |
| Low | -0.95 | -0.98 | -1.03 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.